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Interleukin 18 induces both T helper 1 and T helper 2
cytokines, proin£ammatory cytokines, chemokines,
and IgE and IgG1 production. A role of interleukin 18
in in£ammatory cutaneous reactions is still unclear,
however. Here we generated keratin 5/interleukin 18
transgenic mice overexpressing mature murine inter-
leukin 18 in the skin using a human keratin 5 promoter.
In the contact hypersensitivity model, trinitrochloro-
benzene elicited a stronger ear swelling in keratin 5/in-
terleukin 18 transgenic mice compared with control
littermate wild-type or immunoglobulin/interleukin 18
transgenic mice in which mature interleukin 18 was ex-
pressed by B and Tcells under the control of the immu-
noglobulin promoter. Application of an irritant, croton
oil, induced stronger and more sustained ear swelling in
keratin 5/interleukin 18 transgenic mice than in immu-
noglobulin/interleukin 18 transgenic or wild-type mice.
Repetitive topical application (weekly for six consecu-
tive weeks) of trinitrochlorobenzene to their ears also
elicited a stronger cutaneous in£ammation in keratin
5/interleukin 18 transgenic mice than seen in immuno-
globulin/interleukin 18 transgenic or wild-type mice.
After these six trinitrochlorobenzene applications, the
expression of interferon-c, interleukin-4, and CCL20
mRNA in the ear tissue was increased and dermal
changes, such as acanthosis and eosinophilic, neutro-
philic, and mast cell in¢ltration, were greater in keratin
5/interleukin 18 transgenic mice than in wild-type
mice. Furthermore, the repetitive application elicited a
signi¢cant increase in serum IgE levels and the number
of B cells in the draining lymph node in keratin 5/inter-
leukin 18 transgenic mice. These results suggest that
overexpression of interleukin 18 in the skin aggravates
allergic and nonallergic cutaneous in£ammation, which
is accompanied by high expression of T helper 1 and T
helper 2 cytokines and chemokines in the skin. Key
words: Cytokines/Allergy/in£ammation/transgenic/knockout/
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nterleukin (IL)-18 was originally discovered in the Proprioni-
bacterium acnes-induced toxic shock model as interferon
(IFN)-g inducing factor (Okamura et al, 1995). IL-18 is
intracellularly produced from a biologically inactivated
precursor, pro-IL-18, and mature IL-18 is secreted after the
cleavage of pro-IL-18 by caspase-1, originally identi¢ed as IL-1b
converting enzyme (ICE) (Dinarello, 1999). It has been reported
that pro-IL-18 mRNA is expressed in a wide range of cells,
including Kup¡er cells, macrophages, T cells, B cells, osteoblasts,
keratinocytes, dendritic cells, astrocytes, and microglia, whereas
mature IL-18 is only weakly detected in the sera or tissues
(Dinarello, 1999). IL-18 is biologically similar, although not struc-
turally related, to IL-12, a strong T helper (Th) 1 T cell inducer.
IL-18 is thought to be a strong cofactor in Th1 cell development
(Dinarello, 1999); however, we demonstrated that IL-18 and IL-2
in combination synergistically induced expression of IL-13, aTh2
cytokine, in T cells and a unique IL-13 producing natural killer
cell population (Hoshino et al, 1999).We and other investigators
have reported that IL-18 not only induces production of the Th1
cytokine IFN-g, but also that of Th2 cytokines, including IL-4,
IL-5, IL-10, and IL-13 and IgE and IgG1, in murine model sys-
tems (Yoshimoto et al, 1999, 2000; Hoshino et al, 2000;Wild et al,
2000; Xu et al, 2000; Nakanishi et al, 2001). Recently, we de-
scribed the generation of IL-18 transgenic (TG) mice in which
mature murine IL-18 cDNAwas expressed under the control of
a mouse immunoglobulin promoter (Hoshino et al, 2001). Serum
IgE, IgG1, IL-4, and IFN-g levels were signi¢cantly higher in
these TG mice than their wild-type (WT) counterparts and sple-
nic Tcells from these TG mice produced more IFN-g, IL-4, IL-5,
and IL-13 than those from control WT mice. Moreover, recent
studies suggest that IL-18 plays an important part in the patho-
genesis of asthma, which is a chronic in£ammatory airways
disease characterized by in¢ltration of antigen-speci¢c Th2, or
Th2-like, cells (Nakanishi et al, 2001). These observations indicate
that not only can IL-18 act as a cofactor in bothTh1 and Th2 cell
development, but it may also contribute to allergic disorders.
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Murine contact hypersensitivity (CH) induced by application
of a hapten such as 2,4 -dinitro£uorobenzene (Thomas et al,
1999), trinitrochlorobenzene (TNCB) (Kitagaki et al, 1999), or ox-
azolone (Dieli et al, 1999) is a well-established experimental model
of human contact dermatitis. A previous study found that both
CD4þ and CD8þ T cells play a part in inducing CH (Gocinski
and Tigelaar, 1990). CH was thought to be associated with the ac-
tivation of Th1 typeTcells. It has been demonstrated that in IL-4/
IL-10-producing CD4þ T cells, negatively regulates CH re-
sponse (Xu et al, 1996). Recent studies suggest that both Th1 and
Th2 cytokines such as IFN-g, IL-4, IL-5, and IL-13 expressed at
the site of in£ammation or the draining lymph node play impor-
tant parts in TNCB-induced cutaneous in£ammation in mice
(Dieli et al, 1999; Yokozeki et al, 2000). Repetitive elicitation of
CH response induced by TNCB results in a shift in cutaneous
cytokine expression from a Th1 to a Th2 phenotype (Kitagaki
et al, 1999). Moreover, the requirement of cytokines in CH might
depend on the kind of hapten because IL-4 is required for the
CH reaction to TNCB but not oxazolone (Dieli et al, 1999). The
increased expression of pro-IL-18 mRNA and IL-18 protein by
keratinocytes was reported following oxazolone and dinitro-
chlorobenzene stimulation in mice (Xu et al, 1998) and humans
(Naik et al, 1999), respectively. Furthermore, a recent report re-
vealed that Langerhans cell-derived IL-18 might contribute to
the oxazolone-elicited CH reaction (Wang et al, 2002). Thus,
these results suggest that IL-18 produced at the site of cutaneous
in£ammation is likely to be involved in the manifestation of
these CH reactions.
To elucidate a role of IL-18 in cutaneous in£ammation, we
generated keratin (K) 5/IL-18 TG mice in which keratinocytes ex-
press mouse mature IL-18 fused with the signal peptide (SP) of
the mouse immunoglobulin k-chain under the control of the hu-
man keratinocyte K5 promoter (Sano et al, 1999). The K5/IL-18
TG mice showed not only an aggravated TNCB-elicited CH
reaction but also exacerbated and prolonged croton oil-induced
irritant contact dermatitis compared with WT littermate or im-
munoglobulin/IL-18 TG mice in which mature IL-18 was ex-
pressed by B and T cells (Hoshino et al, 2001). Furthermore, the
repeated elicitation of a CH reaction to TNCB resulted in cuta-
neous in£ammation with more severe histologic changes. These
observations imply that IL-18 plays a crucial part in the aggrava-
tion and prolongation of allergic and nonallergic cutaneous
in£ammation.
MATERIALS AND METHODS
Mice Male and female C57BL/6N (B6) mice were purchased from
Charles River Japan (Yokohama, Japan) and bred in our laboratory.
Immunoglobulin/IL-18 TG mice and theirWT littermates were generated
as described previously (Hoshino et al, 2001). They were housed in plastic
cages in an air-conditioned room at a temperature of 24711C, a humidity
of 55%75% and a 12 h light/dark cycle. All procedures were approved by
the Committee on the Ethics of Animal Experiments, Kurume University
(approval no. 570, 2002). Animal care was provided in accordance with the
procedures outlined in the Guide for the Care and Use of Laboratory Animals
(National Institutes of Health Publication No. 86-23, 1985).
Generation of TG mice expressing mouse mature IL-18 The IL-18
transgene for TG mice was generated as described previously (Hoshino
et al, 2001). Brie£y, mature mouse IL-18 cDNA fused with the SP from
the V-J2-C region of the mouse immunoglobulin k-chain (IL-18SP) were
generated by polymerase chain reaction (PCR) using mouse pro-IL-18
cDNA (provided by Dr Kiyoshi Takeda, Osaka University, Osaka, Japan).
The ampli¢ed IL-18SP DNA was subcloned into the pCR2.1 vector
(Invitrogen, Carlsbad, California), and sequenced. Then, IL-18SP was
subcloned into a pcdEF3 vector containing the human elongation factor
1a promoter and bovine poly(A) signal, (obtained from Dr Jerome
Langer, Robert Wood Johnson Medical School, New Jersey), and was
designated as pEF-IL-18SP. The KpnI/BbsI-digested pEF-IL-18SP DNA
fragment containing IL-18SP and the bovine poly(A) signal was
subcloned into the NotI site of a pBSK vector containing the human K5
promoter (Sano et al, 1999). The BssHII-digested linear DNA fragment
(K5/IL-18SP/poly(A); Fig 1A) was injected into fertilized eggs of B6 mice
at Oriental Bio Service (Kyoto, Japan). Hemizygous TG mice were
generated by mating founder mice with B6 mice and the o¡spring were
screened by the PCR using genomic DNA prepared from their tails, an
enzyme-linked immunosorbent assay for serum mature mouse IL-18
(mIL-18), and western blotting for skin mature mIL-18 as previously
reported (Hoshino et al, 2001).
Induction of CH by an application of TNCB Male K5/IL-18 TG,
male immunoglobulin/IL-18 TG and their age-matched male WT mice
were sensitized by topical application of 100 mL of acetone/olive oil (4:1 v/
v) (vehicle) or 100 mL of 3% (w/v) TNCB (Nacalai Tesque, Kyoto, Japan)
on the shaved abdomen. Six days after the sensitization, an aliquot (10 mL)
of 1% (w/v) TNCB was applied to each site on the surface of the right ear
and the vehicle was applied to the left ear. The thickness of each ear was
measured using an engineering micrometer (SM-112, Teclock, Nagano,
Japan) on blind basis before, and 24 h after TNCB application on
the ear.
Induction of croton oil-induced irritant contact dermatitis Male
K5/IL-18 TG (11 wk old), immunoglobulin/IL-18 TG (10^12 wk old) and
their age-matched WT mice were topically applied by 10 mL of 2% (v/v)
croton oil (Sigma, St Louis, Missouri) to each site on the surface of the
right. The vehicle (acetone/olive oil, 4:1 v/v) was applied on the left ear as
well. The thickness of each ear was measured using an engineering
micrometer on blind basis before, and 6, 24, and 48 h and 7 d after
application.
Induction of contact dermatitis by repeated application of
TNCB Male K5/IL-18 TG (8^11 wk old), immunoglobulin/IL-18 TG
(14 wk old) and their age-matched WT mice were sensitized by topical
application of 10 mL of TNCB (0.25% w/v) or vehicle (acetone/olive oil,
4:1 v/v) to the external and internal surfaces of each ear. TNCB was
applied six times at 1 wk intervals. The thickness of each ear was
measured using an engineering micrometer on blind basis before, and 1, 4,
and 24 h after TNCB application.Twenty-four hours after the sixthTNCB
application, blood was drawn, and the mice were sacri¢ced. A 6 mm
diameter punch biopsy specimen was taken from each left ear,
homogenized in 1 mL 50 mM potassium phosphate bu¡er (pH 6.0)
containing 0.5% hexadecyltrimethylammonium bromide (Sigma),
centrifuged (40,000 g, 10 min), and the supernatant was stored at 801C
until analysis. The remainder of each left ear was ¢xed with 10% formalin-
bu¡ered saline (Nacalai Tesque) for histopathologic analysis, the right ears
were excised for mRNA quanti¢cation and the cervical lymph nodes were
removed for £ow cytometric analysis.
Myeloperoxidase (MPO) and eosinophil peroxidase (EPO)
activities For measuring MPO activity, aliquots (25 mL) of the ear
tissue supernatants and 225 mL of 50 mM potassium phosphate bu¡er (pH
Figure1. (A) Transgene structure. Mature mouse IL-18 cDNA fused
with the SP from the mouse immunoglobulin k-chain was linked to the
human K5 promoter to achieve keratinocyte-speci¢c expression.The trans-
gene construct also contained the K5 polyadenylation sequence to aid in
processing of the transcript and secretion of the protein. pA: bovine
poly(A) signal. (B) TG IL-18 mRNA expression in the ear tissue (left),
and serum IL-18 level (right) from 13 wk old maleWT and K5/IL-18 TG
mice (n¼ 6, each group).
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6.0) containing 167 mg per mL o-dianisidine dihydrochloride (Sigma) and
0.0005% hydrogen peroxide were incubated for 20 min at room
temperature, and their absorbance at 450 nm was measured using a
microplate reader (Spectra Max 250, Molecular Device, Sunnyvale,
California). For measuring EPO activity, aliquots (50 mL) of the
supernatants and 100 mL of 50 mM Tris^HCl bu¡er (pH 8.0) containing
0.1% Triton X-100, 1 mM o-phenylenediamine (Sigma) and 500 mM
hydrogen peroxide were incubated for 30 min at room temperature. The
reaction was stopped by adding 2 M sulfuric acid (50 mL) and the
absorbance at 490 nm was measured using a microplate reader.
Quanti¢cation of cytokines and immunoglobulins Cytokine and
immunoglobulin concentrations were measured using speci¢c enzyme-
linked immunosorbent assay kits; for mouseIL-18 (MBL, Nagoya, Japan),
mIL-4 (R&D Systems, Minneapolis, Minnesota), mouseIFN-g (R&D
Systems), mouseIL-1b (R&D Systems), mouseIgE (Yamasa, Choshi,
Japan), and mouseIgG1 (Bethyl Laboratories, Montgomery, Texas)
according to the manufacturers’ instructions.
Histologic analysis Formalin-¢xed ear tissues were embedded in
para⁄n, cut into 2 mm thick sections, and stained with hematoxylin and
eosin. Alternatively, mast cell granules were identi¢ed by metachromasia
with toluidine blue stain. The number of mast cells in a 2.6 mm
epidermal distance on cross section of skin tissue was microscopically
counted.
Flow cytometric analysis The tissues were digested with Hanks
balanced salt solution containing 1 mg per mL collagenase D (Roche,
Mannheim, Germany) for 25 min at 371C, the reaction was stopped by
adding 500 mM of ethylenediamine tetraacetic acid-2Na to produce a
¢nal concentration of 10 mM, the cells were placed on ice for 5 min and
then washed with RPMI-1640 medium containing 10% heat-inactivated
fetal calf serum (Invitrogen, Tokyo, Japan). Flow cytometric analysis was
performed using an EPICS Flow Cytometer (Beckman Coulter,
Fullerton, California). B lineage cells were detected using a
phycoerythrin-conjugated anti-mouseCD45/B220 monoclonal antibody
(RA3-6B2, rat IgG2a, PharMingen, San Diego, California) and
£uorescein isothiocyanate-conjugated a⁄nity-puri¢ed goat anti-mouse
IgM antibodies (m-heavy chain-speci¢c, LO-MM-9, Zymed, San
Francisco, California). T cell subsets were detected with £uorescein
isothiocyanate-anti-mouseCD4 (GK1.5, PharMingen), phycoerythrin-anti-
mouseCD8a (53-6.7, PharMingen), and CyChrome-anti-mouseCD3
(2C11, PharMingen) monoclonal antibodies. £uorescein isothiocyanate-,
phycoerythrin-, CyChrome-conjugated isotype-matched immuno-
globulin (PharMingen) were used for £ow cytometric analysis. An anti-
mouseCD16/CD32 monoclonal antibody (2.4G2, PharMingen) was used
to block non-speci¢c binding.
Quantitative real-time reverse transcriptase^PCR isolated of total
RNA from mouse ear Each ear tissue was excised, immediately
frozen in liquid nitrogen, pulverized using Cryo-press (Microtech,
Funabashi, Japan), lysed in 1 mL Isogen (Nippon Gene, Tokyo, Japan) at
room temperature, and the total RNA was isolated, according to
manufacturer’s instructions. First strand cDNA were synthesized from
total RNA (2 mg) using a Super Script Preampli¢cation System for First-
Strand cDNA Synthesis kit (Invitrogen, Tokyo, Japan). The synthesized
cDNA (2 mL) in a total reaction volume of 50 mL comprising TaqMan
1000 reaction PCR core reagents (Applied Biosystems Japan, Tokyo,
Japan), 300 nM primers and 200 nM probes was ampli¢ed using
GeneAmp 5700 (Applied Biosynthesis). The mixture solution were
incubated for 2 min at 501C, denatured for 10 min at 951C and subjected
to 45 two-step ampli¢cation cycles each comprising annealing/extension at
601C for 1min followed by denaturation at 951C for 15 s. Sequence-speci¢c
ampli¢cation was detected as an increased £uorescent signal of 6-carboxy-
£uorescein during the ampli¢cation cycle. The primers and probes were
designed using Primer Express software (Applied Biosynthesis) and
synthesized by Invitrogen Japan and Applied Biosynthesis, respectively.
The primer and probe sequences were as follows; mIL-18 transgene sense
primer: 50 -TGGGTACTGCTGCTCTGGGT-30; mIL-18 transgene anti-
sense primer: 50 -ATTCCGTATTACTGCGGTTGTACAG-30; mIL-18
transgene probe: 50 -CCACTGGTGACAACTTTGGCCGACTTC-30; pro-
mIL-18 sense primer: 50 -TCAGGACAAAGAAAGCCGCC-30; pro-mIL-
18 anti-sense primer: 50 -TCTGACATGGCAGCCATTGT-30; pro-mIL-18
probe: 50 -ACCTTCCAAATCACTTCCTCTTGGCCC-30; mIL-12 sense
primer: 50 -AAATGAAGCTCTGCATCCTGC-30; mIL-12 anti-sense
primer: 50 -TCACCCTGTTGATGGTCACG-30; mouseIL-12 probe: 50 -
CACGCCTTCAGCACCCGCG-30; m tumor necrosis factor (mTNF)-a
sense primer: 50 -TCTCTTCAAGGGACAAGGCTG; mouseTNF-a anti-sense
primer: 50 -ATAGCAAATCGGCTGACGGT; mTNF-a probe: 50 -CCCG
ACTACGTGCTCCTCACCCA; mIFN-g sense primer: 50 -AGCTCATCC
GAGTGGTCCAC-30; mIFN-g anti-sense primer: 50 -AGCAGCGACTC
CTTTTCCG-30; mIFN-g probe: 50 -TGTTGCCGGAATCCAGCCTCA
GG-30; mIL-4 sense primer: 50 -GGCATTTTGAACGAGGTCACA-30;
mIL-4 anti-sense primer: 50 -AGGACGTTTGGCACATCCA-30; mIL-4
probe: 50 -CTCCGTGCATGGCGTCCCTTCT-30; mouseCCL20 sense
primer: 50 -GGTGGCAAGCGTCTGCTC-30; mCCL20 anti-sense primer:
50 -GCCTGGCTGCAGAGGTGA-30; mCCL20 probe: 50 -TCCTTGCTTT
GGCATGGGTACTGCTG-30. The sense and anti-sense primers and
probe for mouseGAPDH were purchased from Applied Biosystems.
Ampli¢cation of the genes for mouseGAPDH was performed on all
samples tested to control for variations in RNA contents and all
transcript values were normalized with reference to mGAPDH mRNA
levels. A no-template control was included in each ampli¢cation reaction
to control for contaminating templates. For valid sample analysis, the
£uorescence intensity of the no-template control was required to be zero.
Statistical analysis The results were expressed as mean7SE. Statistical
analyses were carried out using SAS software (SAS Institute Inc., Cary,
North Carolina). Student’s t-test and repeated measure ANOVAwere applied
for the statistical analyses. Di¡erences at p-values of less than 0.05 were
considered to be signi¢cant.
RESULTS
TG mice overexpressing mature IL-18 targeted to
keratinocytes Transfection experiments were carried out to
con¢rm that the transgene construct could induce optimal
secretion of mature IL-18 in vitro. Mature mouse IL-18 cDNA
fused to the SP was subcloned into a pcdEF3 vector containing
the human elongation factor 1a promoter and bovine poly(A)
signal (pEF-IL-18SP) and aliquots (0.5^2 mg) of this construct
were transiently transfected into 293 cells. Mature mouse IL-18
was detected in the supernatants of the pEF-IL-18SP-transfected
293 cells by enzyme-linked immunosorbent assay analysis (data
not shown). The construct design for an IL-18 TG mouse under
the control of the human K5 promoter is shown in Fig 1(A).
One female and three male founders that showed transgene
integration were obtained. K5/IL-18 TG mice were mated with
B6 mice and K5/IL-18 TG andWTo¡spring were generated at a
male/female ratio of approximately 1:1. These K5/IL-18 TG mice
were healthy at birth and grew normally. For most studies shown
below, we used hemizygous mice from the no. 8 founder. The
mRNA of soluble mature IL-18 (transgene) was highly
expressed in the skin tissue of K5/IL-18 TG but not WT mice.
The mean serum IL-18 level of 13 wk old male K5/IL-18 TG
mice was 4.570.7 ng per mL (n¼ 6), in contrast to less than the
detection limit (0.26 ng per mL) inWTmice (Fig 1B). IL-1b, IL-
4, IFN-g, and IgE were undetectable in the sera of these K5/IL-18
TG mice, whereas their serum IgG1 levels were increased with
aging (data not shown). The other three founder lines of K5/IL-
18 TG mice showed similar serum IL-18 levels, IL-18 transgene
expressions in the skin tissues and responses for repetitive TNCB
application, when compared with no. 8 founder line (data not
shown).
CH reaction toTNCB In order to determine the role of IL-18
in the CH response, we examined responsiveness in male K5/IL-
18 TG, immunoglobulin/IL-18 TG and their WT mice. These
mice have been sensitized with a vehicle or TNCB on the
shaved abdomen. Six days after the sensitization, the vehicle and
TNCB was challenged to each site on the surface of the left and
right ear, respectively. No signi¢cant ear swelling was found in
the TG and WT mice that have been sensitized and challenged
with the vehicle. Slight ear swelling was found in the K5/IL-18
TG, immunoglobulin/IL-18 TG and WT mice that have been
sensitized with the vehicle and challenged with TNCB. The
mean increase of ear thickness in these mice was 62.5 mm, 44.0
mm, and 44.0 mm, respectively. Compared with WT mice, the
extent of ear thickness was slightly but signi¢cantly (po0.05)
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increased in K5/IL-18 TG but not in immunoglobulin/IL-18 TG
mice. The mice sensitized with TNCB showed antigen-speci¢c
ear swelling 24 h after challenge with TNCB but not the
vehicle. Compared with WT mice, the extent of ear swelling
was signi¢cantly increased in K5/IL-18 TG mice but not in
immunoglobulin/IL-18 TG mice (Fig 2).
Irritation response to a topical application of croton oil We
examined the cutaneous response after challenge of croton oil in
K5/IL-18 TG and immunoglobulin/IL-18 TG mice to determine
a role of IL-18 in the skin (Fig 3). After topical application of 2%
croton oil, signi¢cant ear swelling was detected at 6 and 24 h, and
disappeared at 48 h in WT mice. In K5/IL-18 TG mice, the
signi¢cant ear swelling was sustained until 48 h after the
challenge with the croton oil. There was no signi¢cant
di¡erence in the croton oil-induced ear swelling between
immunoglobulin/IL-18 TG and theWTmice.
Dermatitis caused by repetitive topical application of TNCB
As described above, CH reaction caused by TNCB and ear
swelling caused by croton oil in K5/IL-18 TG mice was stronger
than those in immunoglobulin/IL-18 TG andWTmice. Next, we
examined the responsiveness by repetitive exposure of TNCB in
the ears of K5/IL-18 TG mice to evaluate the role of IL-18 in
chronic skin in£ammation. The ear thickness was measured 1, 4,
and 24 h after the second to sixth TNCB applications. Six
repeated topical applications of TNCB to the ears induced CH
responses and two peaks of ear thickness were observed 1 and 24
h after the second to sixth TNCB treatments in K5/IL-18 TG,
immunoglobulin/IL-18 TG and WT mice (Fig 4); however, the
extent and the duration of the ear swelling after each TNCB
application was much greater in K5/IL-18 TG than observed in
WT mice. In addition, the ear swelling in K5/IL-18 TG mice
was cumulatively increased as it had not subsided by the next
elicitation with TNCB in contrast to the results observed inWT
mice. There was no signi¢cant di¡erence in ear swelling between
immunoglobulin/IL-18 TG and WT mice in the repetitive
TNCB-induced chronic ear swelling analysis.
In order to quantify in£ammatory cell in¢ltration of the skin
tissue, the MPO and EPO activities were determined and the
numbers of mast cells in toluidine blue-stained specimens were
counted (Fig 5). In TNCB-treated K5/IL-18 TG and WT mice,
the MPO and EPO activities and numbers of mast cells were
signi¢cantly higher than those in the corresponding vehicle-
treated mice. Moreover, the MPO and EPO activities and
numbers of mast cells were signi¢cantly higher in the TNCB-
treated K5/IL-18 TG than the correspondingWTmice; however,
there were no di¡erences between the MPO or EPO activities or
the numbers of mast cells in vehicle-treatedWTand K5/IL-18 TG
mice.
Figure 3. Ear thickness of K5/IL-18 TG, immunoglobulin/IL-18 TG
and WTmice after topical application of an irritant croton oil.The
mice were topically applied by 10 mL of 2% croton oil to each site on the
surface of the right ear and 10 mL of vehicle (acetone/olive oil, 4:1 v/v) on
the left ear as well. The ear thickness was determined 6 h, 24 h, 48 h, and
7 d after application. Repeated experiments were performed, and the repre-
sentative data is shown. Data represent the mean7SEm of ¢ve animals.
##po0.01, signi¢cantly di¡erent from the correspondingWTmice (Stu-
dent’s t test).
Figure 2. Ear thickness of K5/IL-18 TG, immunoglobulin/IL-18 TG
and their littermateWTmice after TNCB-elicited CH reaction. K5/
IL-18 TG and their littermateWT, or immunoglobulin/IL-18 TG and their
littermateWTmice were sensitized by topical application of 100 mL of 3%
(w/v) TNCB on the shaved abdomen. Six days after the sensitization, 10 mL
of 1% (w/v) TNCB was applied to each site on the surface of the right ear
and the vehicle (acetone/olive oil, 4:1 v/v) was applied to the left ear. The
ear thickness was determined 24 h after elicitation. Repeated experiments
were performed, and the representative data is shown. Data represent the
mean7SEm for six animals. po0.01, signi¢cantly di¡erent from the
corresponding vehicle (V)-treated mice (Student’s t test), ##po0.01, sig-
ni¢cantly di¡erent from the correspondingWTmice (Student’s t test).
Figure 4. Increase (%) in ear thickness following repeated applica-
tion of TNCB to the ears of K5/IL-18 TG, immunoglobulin/IL-18
TG and theirWTmice.TNCB (0.25%) or vehicle was applied topically
to both ears of each mouse once a week for 6 wk. The ear thickness was
determined 1, 4, and 24 h after the second to sixthTNCB applications. Re-
peated experiments were performed twice, and the representative data are
shown. Data represent the mean7SEm for six mice for K5/IL-18 TG and
four mice for immunoglobulin/IL-18 TG mice. Two group comparison
was performed by repeated measures ANOVA. In K5/IL-18 TG mice (upper
panel), the group e¡ect was statistically di¡erent in TG TNCB versusWT
TNCB (p¼ 0.0089), TG TNCB versus TG vehicle (p¼ 0.001), and WT
TNCB versusWTvehicle (pp0.0001), but not in TG vehicle versusWT ve-
hicle (p¼ 0.2996). In immunoglobulin/IL-18 TG mice (lower panel), the
group e¡ect was statistically di¡erent in TG TNCB versus TG vehicle
(p¼ 0.0045) and WT TNCB versus WT vehicle (p¼ 0.0007), but not in
TG TNCB versus WT TNCB (p¼ 0.0531); TG vehicle versus WT vehicle
(p¼ 0.6036).
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As described above, serum levels of IL-18 were higher in K5/
IL-18 TG mice than those in WT mice. After the sixth TNCB
treatment, the serum IL-18 levels showed a tendency to increase
in K5/IL-18 TG mice (data not shown). Although the serum level
of IgE was undetectable (p0.25 mg per mL) in both vehicle-
treated K5/IL-18 TG andWTmice, the repetitive treatment with
TNCB increased serum IgE levels to 0.770.3 mg per mL (n¼ 6)
in K5/IL-18 TG but undetectable inWTmice. The serum levels
of IL-1b, IL-4, and IFN-g were undetectable in both K5/IL-18
TG and WT mice treated with vehicle or TNCB (data not
shown).
Histopathologic changes in the skin after repetitive
treatment with TNCB The skin tissues were harvested
24 h after the sixth applications of vehicle or TNCB, and
hematoxylin and eosin sections were then microscopically
examined. Whereas vehicle treatment did not induce histologic
skin damages in WT mice (Fig 6aA and E, 6bA), TNCB
treatment induced mild acanthosis and thickness of the dermis
with edema and in¢ltration of mononuclear cells (Fig 6aB and
F, 6bB). In TNCB-treated K5/IL-18 TG mice, more severe
hyperkeratosis, acanthosis, migration of in£ammatory cells into
the epidermis (exocytosis), and swelling of the dermis were
observed than seen in WT mice (Fig 6aD and H, 6bD).
Consistent with these histologic results, we found higher MPO
and EPO activities in TNCB-treated K5/IL-18 TG mice than the
correspondingWTmice (Fig 5). It is worth to note that vehicle-
treated K5/IL-18 TG but not WT mice showed only but
signi¢cant epidermal hyperplasia with nuclear swelling of
keratinocytes and in¢ltration of mononuclear cells and
eosinophils in the dermis (Fig 6aC and G, 6bC).
Altered cell populations in the lymph nodes after repetitive
treatment with TNCB As shown in Table I, the percentage
and absolute number of B lineage cells in lymph nodes from
vehicle-treated K5/IL-18 TG mice were signi¢cantly higher than
those of vehicle-treated WT mice. Following the repetitive
Figure 5. MPO and EPO activities and mast cell in¢ltration of the
in£amed lesions caused by repeated application of TNCB in K5/IL-
18 TG and WTmice.The skin tissue was excised 24 h after the ¢nal ap-
plication of TNCB or vehicle, the MPO and EPO activities of the tissue
samples were measured to obtain indices of the numbers of neutrophils
and eosinophils, respectively, and the mast cells in a 2.6 mm epidermal
length were counted on toluidine blue-stained skin specimens. Data repre-
sent the mean7SEm value for ¢ve or six mice. po0.05, po0.01, signif-
icantly di¡erent from the corresponding vehicle-treated mice (Student’s t
test), #po0.05, ##po0.01, signi¢cantly di¡erent from the correspond-
ingWTmice (Student’s t test).
Figure 6. Histopathology of ear skin lesions caused by repeated ap-
plication of TNCB in K5/IL-18 TG and WT mice. The skin tissues
were excised 24 h after the ¢nal application of vehicle or TNCB and for-
malin-¢xed/para⁄n embedded sections were stained with hematoxylin
and eosin (a). Toluidine blue staining was also performed for the detection
of mast cells (arrow) (b). (a) A and E: vehicle-treatedWT; B and F: TNCB-
treatedWT. C and G:Vehicle-treated TG. D and H:TNCB-treated TG. (b)
A: Vehicle-treated WT. B: TNCB-treated WT. C: Vehicle-treated TG. D:
TNCB-treated TG. Original magni¢cation: (a) A^D100, E^H 400;
(b) A^D 400. Bar¼ 50 mm.
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TNCB treatment, the percentage and absolute number of B
lineage cells in lymph nodes were signi¢cantly increased inWT
mice; however, the number of B lineage cells was increased more
signi¢cantly in K5/IL-18 TG mice compared with those in WT
mice. Also the absolute number of CD4þ and CD8þ T cells
was increased in K5/IL-18 TG mice after the repetitive TNCB
treatment.
Expression of mRNA for cytokines and chemokines in skin
tissue after repetitive treatment with TNCB In order to
investigate the involvement of cytokines and chemokines in the
TNCB-induced chronic skin in£ammation, the expression levels
of mRNA for pro-IL-18, IL-12, IFN-g, IL-4, TNF-a, and
CCL20 in ear tissues collected 24 h after the sixth TNCB
application were measured using quantitative real-time reverse
transcriptase^PCR. As shown in Fig 7, the repetitive treatment
with TNCB increased the expression of mRNA for pro-IL-18
(not transgene-derived mature IL-18 mRNA), IFN-g, IL-4, and
CCL20 mRNA in both WT and K5/IL-18 TG mice. IL-12 and
TNF-a mRNA expressions were signi¢cantly increased by the
repetitive treatment with TNCB in K5/IL-18 TG mice as
compared with corresponding vehicle-treated mice. The
magnitudes of the increased expression of mRNA for IFN-g,
IL-4, and CCL20 were 2-fold or higher in K5/IL-18 TG mice as
compared withWTmice, although the increases in IFN-g, IL-4,
and CCL20 observed in the TG mice were not statistically
signi¢cant. There were no di¡erences between the cytokine/
chemokine mRNA expression levels in vehicle-treated K5/IL-18
TG andWTmice.
DISCUSSION
Keratinocytes are major producers of IL-18 and constitutively
produce it as an inactive precursor (Companjen et al, 2000; Mee
et al, 2000). Pro-IL-18 is cleaved by caspase-1 to produce biologi-
cally active IL-18, which is secreted after treatment with pro-in-
£ammatory mediators by keratinocytes (Naik et al, 1999). In
psoriasis, the immunoreactive IL-18 in extracts of psoriatic scales
contained the mature form of IL-18. Thus, in chronic skin in-
£ammation, pro-IL-18 may be rapidly processed, followed by
the release of active mature IL-18 by keratinocytes.
In this study, we generated IL-18 TG mice under the control of
the human K5 promoter. These TG mice exhibited high serum
levels of IL-18 but not IFN-g, IL-4, and IgE. The serum IL-18
concentration of the K5/IL-18 TG mice at 13 wk old, was
4.570.7 ng per mL (n¼ 6), whereas that of age-matched WT
mice was undetectable. This observation indicates that implanted
mature IL-18 with immunoglobulin SP was secreted by K5-ex-
pressing keratinocytes (Sano et al, 1999) and entered the systemic
circulation. In a recent study on immunoglobulin/IL-18 TG mice,
B and mature T cells of which could express mature IL-18 under
the control of an IgH promoter (Hoshino et al, 2001), the immu-
noglobulin/IL-18 TG mice exhibited high serum levels of IFN-g,
IL-4, and IgE. Thus, K5/IL-18 TG mice has weaker e¡ects on
aberrant production of both of Th1 and Th2 cytokines compared
with immunoglobulin/IL-18 TG mice. Although the precise re-
ason remains unclear, the lower serum IL-18 level (7.670.9 ng
per mL, n¼ 3 for immunoglobulin/IL-18 TG mice) and the dif-
ferences in cell types where IL-18 is overexpressed might be asso-
ciated with less aberrant cytokine production in K5/IL-18 TG
mice.
K5/IL-18 TG mice used in this study exhibited no spontaneous
skin abnormalities until they were about 16 wk old. In contrast,
elicitation of skin abnormalities due to ICE (Yamanaka et al,
2000), IL-4 (Tepper et al, 1990), and IFN-g (Carroll et al, 1997)
overexpression has been demonstrated by studies on TG mice.
When skin-speci¢c ICE TG mice reached 8 wk of age, they ex-
hibit high serum IL-18 and IL-1b levels and severe dermatitis
characterized by apoptosis of keratinocytes. In the ICE TG
mouse, ICE-induced apoptotic tissue injury and elevated systemic
proin£ammatory cytokine levels are thought to contribute to the
serious dermatitis (Yamanaka et al, 2000). In IL-4 TG mice, facial
atopy-like dermatitis accompanied by eosinophilic in¢ltration
Table I. Lymphoid cells were isolated from the cervical lymph nodes of K5/IL-18 TG and theirWTmice treated with
TNCB or vehicle, as described in Materials and Methods. The cells were subjected to £ow cytometric analysis with £uorescein
isothiocyanate-conjugated anti-mCD4, PE-anti-mCD8, PE-anti-mCD45/B220 monoclonal antibodies, and £uorescein
isothiocyanate-anti-mIgM antibody. Each value represents the mean7SEl for three mice
Total cells (107) CD4þ T cells (%) CD8þ T cells (%) B lineage (B220þ IgMþ ) cells (%)
WTþvehicle 1.2770.27 27.772.7 18.572.3 41.472.9
(3.7106) (2.4106) (5.2106)
WTþTNCB 1.8170.15 18.372.4 13.872.6 55.270.6b
(3.4106) (2.6106) (1.0107a)
TGþvehicle 1.6170.18 19.071.2 15.571.5 53.271.0c
(3.1106) (2.5106) (8.6106)
TGþTNCB 4.0570.54ac 14.872.1 11.871.9 64.575.9
(5.9106a) (4.9106) (2.7107ac)
The mean absolute number of cells was shown in parentheses. apo0.05, bpo0.01, signi¢cantly di¡erent from the group treated with corresponding vehicle; cpo0.05,
signi¢cantly di¡erent from the correspondingWTgroup.
Figure 7. Expression of mRNA for cytokines and chemokines in
in£amed skin of K5/IL-18 TG and WTmice.The ear tissues were ex-
cised from the mice 24 h after the sixth application of TNCB or vehicle.
The total RNAwas extracted from the tissues and the cytokine and che-
mokine expression levels were determined by semi quantitative real-time
reverse transcriptase^PCR methods. All transcript values (expression ra-
tios) were normalized according to the expression levels of a housekeeping
gene GAPDH. Data represent the mean7SEm for three mice (each in du-
plicate). po0.05, po0.01, signi¢cantly di¡erent from the correspond-
ing vehicle-treated mice (Student’s t test). ND: not detectable.
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and high serum IgE production have been reported (Tepper
et al, 1990). Three week old TG mice that overproduced IFN-g in
their skins have also been reported to exhibit skin abnormalities
accompanied by accumulation of T cells, monocytic cells, and
Langerhans cells (Carroll et al, 1997). Thus, the apparent skin con-
dition of K5/IL-18 TG mice seems to di¡er from that of ICE TG
or IL-4 TG or IFN-g TG mice unless the mouse skin was sub-
jected to any stimulation.
Compared with immunoglobulin/IL-18 TG or WT mice, the
ear swelling resulting from CH reaction to TNCB was signi¢-
cantly enhanced 24 h after the challenge in K5/IL-18 TG mice.
As a recent study (Wang et al, 2002) implicated IL-18 in the
pathogenesis of CH response to oxazolone, our present data indi-
cated a role for IL-18 in the CH response toTNCB. Furthermore,
the ear swelling after application of croton oil signi¢cantly
increased and was prolonged in K5/IL-18 TG but not immuno-
globulin/IL-18 TG orWTmice. These observations indicate that
IL-18 may act as an aggravating factor in not only nonallergic but
also allergic cutaneous in£ammation, such as CH. Also, IL-18 lo-
cally produced from the skin tissue but not from lymphocytes
likely contributes to the aggravation of these cutaneous in£am-
mations. The ability of IL-18 to prolong cutaneous in£ammation
prompts us to examine the potential role of IL-18 on chronic al-
lergic contact dermatitis.
As was expected, the repetitive application of TNCB to the
ears of K5/IL-18 TG mice elicited more severe dermatitis than
that of immunoglobulin/IL-18 or WT mice. Enhanced in¢ltra-
tion of neutrophils, eosinophils, and mast cells was observed in
the TNCB-treated K5/IL-18 TG mice in comparison with that
in WT mice. Histopathologic examination revealed that TNCB
treatment to the ears induced more severe epidermal hyperplasia
and extravasation of in£ammatory cells and edema in the dermis
in K5/IL-18 TG than in WT mice (Fig 6). Besides an ability of
IL-18 to induce IFN-g production byT cells, natural killer cells,
and natural killer T and B cells (Dinarello, 1999), direct e¡ects of
IL-18 on neutrophils (Leung et al, 2001), eosinophils (Wang et al,
2001), and basophils (Yoshimoto et al, 1999) were reported. IL-18
not only acts as a chemoattractant to neutrophils but also activates
expression of TNF-a mRNA by neutrophils (Leung et al, 2001).
Induction of eosinophil-derived IL-8 production by IL-18 (Wang
et al, 2001) may be responsible for neutrophilic migration to in-
£amed sites. IL-18 has also been reported to stimulate histamine
and IL-4 release by basophils (Yoshimoto et al, 1999). Thus in
K5/IL-18 TG mice, a continuous recruitment of in£ammatory
cells and production of cytokines or growth factors at the in-
£amed site might underlie the exacerbated in£amed cutaneous
reaction, which is a result of the continuous production of IL-18
in the skin.
We investigated the possible involvement of cytokines and
chemokines in TNCB-induced CH by measuring expression le-
vels of mRNA for pro-IL-18, IL-12, IFN-g, IL-4, TNF-a, and
CCL20 in ear skin tissues using a quantitative real-time reverse
transcriptase^PCR (Fig 7). The repetitive TNCB application eli-
cited higher expression of mRNA for Th1 (IFN-g) and Th2
(IL-4) cytokines and chemokines (CCL20) in the skin tissue in
K5/IL-18 TG than inWTmice. IFN-g is a strong inducer of pro-
duction of adhesion molecules and chemokines, including
CCL20 (Homey et al, 2000). The expression of CCL20, which
can be secondarily induced by IL-12 and IL-18 via IFN-g pro-
duction, from keratinocytes, dermal ¢broblasts, dermal microvas-
cular endothelial cells, and dendritic cells is reported to attract the
memory subset of T cells and dendritic cells, especially epithelial
Langerhans-type dendritic cells (Homey et al, 2000). As antigen-
presenting cells and lymphocytes have been suggested to make a
signi¢cant contribution to the CH response, IL-12, IFN-g, and
CCL20 produced at in£ammatory sites may play a part in the ex-
aggerated in£ammatory reaction observed in K5/IL-18 TG mice.
IL-4 is thought to be one of the factors that aggravate TNCB-in-
duced CH (Kitagaki et al, 1999) because of a reduced severity of
the response to TNCB in IL-4-de¢cient mice (Dieli et al, 1999)
and STAT (signal transducer and activator of transcription) 6-de-
¢cient mice (Yokozeki et al, 2000). In addition, IL-4 is known to
be a strong activator of mast cells. Histamine, a major chemical
mediator released by activated mast cells/basophils, was reported
to induce IL-18 production by human peripheral mononuclear
cells (Kohka et al, 2000).Thus, in addition to the anticipated direct
e¡ect of IL-18 on the in£ammatory cells, the upregulation of Th1
and Th2 cytokines and chemokines may be involved in the ex-
acerbation of CH responses through positive feedback.
In addition to the pathologic changes in the skin,TNCB treat-
ment also a¡ected serum cytokine and immunoglobulin levels,
and the cell numbers and populations in draining lymph nodes.
Although elevated serum IgE levels have been reported in models
of 2,4 -dinitro£uorobenzene-induced CH (Nagai et al, 2000) and
TNCB-induced CH (Yokozeki et al, 2000), the serum IgE level
was not detectable inWT mice in this study. A high serum IgE
level was detected only in TNCB-treated K5/IL-18 TG mice but
not vehicle-treated K5/IL-18 TG mice. Thus, the repetitive
TNCB-elicited CH response in this study might be a relatively
weak immunologic reaction compared with other reports
(Yokoze ki et al, 2000; Nagai et al, 2000). A synergistic e¡ect of
the transgene-derived IL-18, such as enhanced cutaneous IL-4
production, may have resulted in the elevated serum IgE levels
in this model. As reported previously, mice exposed to contact
allergens such asTNCB showed a signi¢cant increase in B lineage
cells compared with irritants such as benzalkonium chloride or
sodium lauryl sulfate (Gerberick et al, 1999). In this repeated
TNCB-induced CH model, the percentage of B lineage cells
was highest in the TNCB-treated K5/IL-18 TG mice where the
strongest cutaneous in£ammation was elicited (Table I). Thus
the increased IgE production and B lineage cell population in
draining lymph nodes implies that IL-18 enhances the immune
response in this repeated TNCB-induced CH model as well as
in£ammation itself.
In this study, we showed that excessive production of IL-18 by
keratinocytes aggravated the CH response. Recent studies showed
that serum IL-18 levels in patients with atopic dermatitis and in a
murine atopic dermatitis model were higher than the respective
control levels (Tanaka et al, 2001). More recently, Konishi et al
(2002) reported that keratinocyte-speci¢c overexpressed IL-18
TG mice under the control of human K14 promoter developed
atopic dermatitis-like skin lesions at about 24 wk under the spe-
ci¢c pathogen free conditions (Konishi et al, 2002). Our female
K5/IL-18 TG mice also show hair-loss and erosion of the back
skin at about 18 wk after birth (manuscript in preparation); how-
ever, we did not observe spontaneous skin disorder in the 7 to 17
wk old K5/IL-18 TG mice that we used in this study. These ¢nd-
ings suggest that IL-18 acts as a factor that causes deterioration
rather than induction, of allergic and nonallergic skin orders.
Further analysis should be needed to clarify this issue.
In conclusion, K5/IL-18 TG mice exhibited more severe
TNCB-induced CH than immunoglobulin/IL-18 TG or WT
mice. Application of an irritant (croton oil) induced stronger
and more sustained ear swelling in K5/IL-18 TG mice than in
immunoglobulin/IL-18 TG orWTmice. Repetitive topical appli-
cation of TNCB to their ears elicited a stronger cutaneous in-
£ammation in K5/IL-18 TG mice than seen in immunoglobulin/
IL-18 TG orWTmice. In addition to a direct e¡ect of IL-18 on
in£ammatory cells, upregulation of various cytokines and chemo-
kines by IL-18 at in£amed sites may contribute to the exacerbation
of cutaneous in£ammation in these TG mice. Our results suggest
that overexpression of IL-18 in the skin is a critically important
therapeutic target in both allergic and nonallergic dermatitis.
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